Kadmon Holdings, Inc. is a company in the U.S. stock market and it is a holding in 36 U.S.-traded ETFs. KDMN has around 18.9M shares in the U.S. ETF market. The largest ETF holder of KDMN is the SPDR S&P Biotech ETF (XBI), with approximately 7.52M shares. Investors may also find of interest that the ETF with the largest allocation to KDMN stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.67%. On average, U.S. ETFs allocate 0.10% of KDMN to their portfolios.
Additionally, KDMN is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with KDMN as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.